AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab Chemotherapy Followed by Adjuvant Durvalumab in Patients with Resectable NSCLC | OncLive
AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab Chemot…
May 19, 2023
onclive.com
Dr Querfeld on Durvalumab Plus Lenalidomide vs Durvalumab in Advanced Cutaneous T-Cell Lymphoma | OncLive
Dr Querfeld on Durvalumab Plus Lenalidomide vs Durvalumab in A…
Jan 22, 2025
onclive.com
Highlights of Durvalumab for Advanced Bladder Cancer
Highlights of Durvalumab for Advanced Bladder Cancer
Apr 22, 2017
onclive.com
FDA Approval of Durvalumab for Advanced Bladder Cancer
FDA Approval of Durvalumab for Advanced Bladder Cancer
Apr 22, 2017
onclive.com
7.7K views · 52 reactions | In patients with muscle-invasive bladder cancer, recurrences after standard treatment are common. Adding perioperative durvalumab to standard treatment may improve outcomes. Research findings are summarized in a new Quick Take video. Full research findings in comments. | The New England Journal of Medicine | Facebook
2:30
7.7K views · 52 reactions | In patients with muscle-invasive blad…
1.7K views2 weeks ago
FacebookThe New England Journal of Medicine
9.2K views · 46 reactions | No new advances in systemic treatments for limited-stage small-cell lung cancer have been made for decades. Research findings on adjuvant therapy with durvalumab are summarized in a new Quick Take video. https://nej.md/4d0eZ5m | The New England Journal of Medicine | Facebook
2:08
9.2K views · 46 reactions | No new advances in systemic treatments f…
1.7K views2 weeks ago
FacebookThe New England Journal of Medicine
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Dec 28, 2023
reachmd.com
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab S…
Feb 10, 2018
onclive.com
HIMALAYA Trial: First-Line Tremelimumab Plus Durvalumab I…
Oct 2, 2022
ascopost.com
1:29
FDA Approves Perioperative Durvalumab Plus Chemo for Musc…
10 months ago
onclive.com
Durvalumab Vs. Chemotherapy in Previously Untreated Patients wit…
Feb 2, 2021
urotoday.com
3:26
Immunotherapy Advances in SCLC: Unlocking Treatment Potential
2 months ago
YouTubeThe Shared Voice
4:23
Imfinzi FDA Approval: New Immunotherapy for Early Gastric …
2 months ago
YouTubeWorldwide Reflections
2:18
CALYPSO: final efficacy data and biomarker analysis in the ccRCC c…
15 views2 months ago
YouTubeVJOncology
7:47
Durvalumab and BCG: A New Treatment Option for High-Risk Bl…
1 views2 months ago
YouTubeThe Open Forum
0:51
Marcel D’Allende survived Lung Cancer | carboplatin | pemetrexed …
794 views1 month ago
YouTubeCancer Interviews
4:04
Immunotherapy Advances in SCLC: What You Need to Know
2 months ago
YouTubeVoices Without Borders
5:34
Immunotherapy Advances in SCLC: What We Know and What's Next
1 views2 months ago
YouTubeTimeless Connection
Durvalumab plus bevacizumab, added to TACE, shows benefit for …
74 viewsFeb 20, 2024
YouTubeecancer
ascor-gi-2025-insights-real-world-outcomes-of-durvalumab-tremeli…
10 months ago
vumedi.com
Pronunciation of the word(s) "Durvalumab".
4.6K viewsSep 25, 2020
YouTubeSAYTHEWORD-Learn English Pronunciations …
WATCH: Dr Senan Discuss the Significance of the FDA Approval …
224 viewsDec 7, 2024
YouTubeOncLive
4:25
Durvalumab Tolerability in Non–Small Cell Lung Cancer
1.3K viewsFeb 25, 2020
YouTubeTargeted Oncology
2:12
Cancer immunotherapy | The PD-L1 pathway
214.2K viewsMay 26, 2016
YouTubeRoche
6:47
Immunotherapy and the side effects
HIGHLY RANKED HOSPITAL
About this channel
YouTubeSunnybrook Hospital
1:06
The Mechanism of Action of Durvalumab in the Treatment of Ur…
1.5K viewsAug 10, 2016
YouTubeTargeted Oncology
30:53
Immunotherapy Side Effects: What Patients Need to Know with Dr. Je…
113.7K viewsSep 9, 2020
YouTubeCancer Research Institute
6:29
Durvalumab ( Imfinzi ) for HCC
264 viewsAug 15, 2024
YouTubePharmComm
1:37
How to pronounce durvalumab
1.7K viewsAug 25, 2021
YouTubeBiomedical Pronunciation Guide
See more videos
Static thumbnail place holder